These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 19687151)
1. Different effects of ketoconazole on the stereoselective first-pass metabolism of R/S-verapamil in the intestine and the liver: important for the mechanistic understanding of first-pass drug-drug interactions. Thörn HA; Hedeland M; Bondesson U; Knutson L; Yasin M; Dickinson P; Lennernäs H Drug Metab Dispos; 2009 Nov; 37(11):2186-96. PubMed ID: 19687151 [TBL] [Abstract][Full Text] [Related]
2. Binding processes determine the stereoselective intestinal and hepatic extraction of verapamil in vivo. Thörn HA; Sjögren E; Dickinson PA; Lennernäs H Mol Pharm; 2012 Nov; 9(11):3034-45. PubMed ID: 23009633 [TBL] [Abstract][Full Text] [Related]
3. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism. Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats. Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604 [TBL] [Abstract][Full Text] [Related]
5. Input rate-dependent stereoselective pharmacokinetics. Experimental evidence in verapamil-infused isolated rat livers. Mehvar R; Reynolds J Drug Metab Dispos; 1995 Jun; 23(6):637-41. PubMed ID: 7587945 [TBL] [Abstract][Full Text] [Related]
6. In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole. Lundahl A; Hedeland M; Bondesson U; Lennernäs H Drug Metab Dispos; 2011 May; 39(5):847-57. PubMed ID: 21317368 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry. Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL J Pharm Biomed Anal; 2007 Dec; 45(5):762-8. PubMed ID: 17981422 [TBL] [Abstract][Full Text] [Related]
8. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. Sandström R; Knutson TW; Knutson L; Jansson B; Lennernäs H Br J Clin Pharmacol; 1999 Aug; 48(2):180-9. PubMed ID: 10417494 [TBL] [Abstract][Full Text] [Related]
9. Chiral capillary electrophoretic analysis of verapamil metabolism by cytochrome P450 3A4. Ha PT; Sluyts I; Van Dyck S; Zhang J; Gilissen RA; Hoogmartens J; VanSchepdael A J Chromatogr A; 2006 Jul; 1120(1-2):94-101. PubMed ID: 16376901 [TBL] [Abstract][Full Text] [Related]
10. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding. Mehvar R; Reynolds J Drug Metab Dispos; 1996 Oct; 24(10):1088-94. PubMed ID: 8894509 [TBL] [Abstract][Full Text] [Related]
11. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys. Ogasawara A; Kume T; Kazama E Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of gut and hepatic first-pass loss of verapamil in intestinal and vascular access-ported (IVAP) rabbits. Kunta JR; Lee SH; Perry BA; Lee YH; Sinko PJ Drug Metab Dispos; 2004 Nov; 32(11):1293-8. PubMed ID: 15304428 [TBL] [Abstract][Full Text] [Related]
13. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Kharasch ED; Walker A; Hoffer C; Sheffels P Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460 [TBL] [Abstract][Full Text] [Related]
14. Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats. Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL Chirality; 2010 Jan; 22(1):29-34. PubMed ID: 19229957 [TBL] [Abstract][Full Text] [Related]
15. First-pass effects of verapamil on the intestinal absorption and liver disposition of fexofenadine in the porcine model. Petri N; Bergman E; Forsell P; Hedeland M; Bondesson U; Knutson L; Lennernäs H Drug Metab Dispos; 2006 Jul; 34(7):1182-9. PubMed ID: 16621934 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects. Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016 [TBL] [Abstract][Full Text] [Related]
17. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats. Sandström R; Lennernäs H Drug Metab Dispos; 1999 Aug; 27(8):951-5. PubMed ID: 10421625 [TBL] [Abstract][Full Text] [Related]
18. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey. Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938 [TBL] [Abstract][Full Text] [Related]
19. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human. Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407 [TBL] [Abstract][Full Text] [Related]
20. PBPK modeling to unravel nonlinear pharmacokinetics of verapamil to estimate the fractional clearance for verapamil N-demethylation in the recirculating rat liver preparation. Yang QJ; Si L; Tang H; Sveigaard HH; Chow EC; Pang KS Drug Metab Dispos; 2015 Apr; 43(4):631-45. PubMed ID: 25650380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]